Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Search stories

Type at least two characters. Results come from every newsroom baba reads.

to move · to open · esc to close

Live Terminal

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

Keep the whole picture

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Court Orders Verso to Pay Omer Adam and Opticana $800,000 Each

By ג'ניפר סילון
Translated & summarized from Globes by baba
The story · English

An Israeli court has ruled in a complex legal dispute involving the eyewear brand Verso, singer Omer Adam, and the Opticana chain, ordering Verso and its representative David Amar to pay a total of approximately $866,000 to Adam's company, P.A.I Production, and approximately $800,000 net to Opticana.

The legal battle originated from a 2018 agreement where Omer Adam was to become the brand ambassador for Verso in Israel, with profits to be shared equally. Later, an agreement was made with Opticana for a non-exclusive license to use the Verso trademark for marketing and sales in Israel. Verso claimed Opticana infringed on the brand's rights, used substandard materials, and produced unauthorized products, causing them an estimated $10 million in damages.

Opticana countered, stating the initial partnership failed due to lack of experience and that they received exclusive distribution rights, investing millions in advertising. They alleged that faulty inventory necessitated a new collection, and a subsequent tripartite agreement for Opticana to acquire a third of the brand's proprietary rights was reneged upon by Verso, leading to their claim for $13 million.

Omer Adam's company, P.A.I Production, also sued Verso and David Amar, alleging misrepresentation regarding Verso's experience and reputation. The court ultimately found in favor of P.A.I Production and Opticana, awarding them damages that, after accounting for mutual claims, resulted in Opticana receiving a net payment of $800,000 and P.A.I Production receiving $866,000 from Verso and David Amar.

Verso stated they are reviewing the court's decision. Opticana was represented by M. Firon & Co., while P.A.I Production was represented by Altshuler Law Firm.

Read the original at Globes
Full coverage · 6 outlets
67% right-leaningFirst: Ice · 4h ago

The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.

Center 1Right 2Unrated 3
Related stories · 5

Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.

Open the live terminal